Data Management And Sharing System of China National Clinical Research Center for Neurological Diseases
Neuroimaging Advances in Preclinical Alzheimers disease
First author：Can Sheng
Corresponding author：Yue Huang, Fang Liu
essential_information
2018-08-01
Published articles
Background And Purpose
Method
Recently, due to the advanced neuroimaging techniques and biochemical tests, various biomarkers are gradually identified, providing the ability to detect the evidence of AD pathology in the preclinical stage and further intervene the process of disease. Multimodal magnetic resonance imaging (MRI), with relatively non-invasive and economic benefits, is of great values to promote the clinical application.
Conclusion
Therefore, researches involving brain structural and functional alterations in preclinical AD are summarized in this review.